Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder
NCT07420816
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
222
Enrollment
INDUSTRY
Sponsor class
Conditions
Insomnia
Insomnia Chronic
Interventions
DRUG:
APSTZD 1
DRUG:
APSTZD 2
DRUG:
APSTZD 3
DRUG:
APSTZD 4
DRUG:
Stilnox CR®
DRUG:
Placebo
Sponsor
Apsen Farmaceutica S.A.